Residual inflammatory risk after contemporary lipid lowering therapy

Riaz, H; Khan, SU; Lateef, N; Talluri, S; Khan, MS; Desai, MY

Riaz, H (corresponding author), Cleveland Clin, Dept Cardiol, Heart & Vasc Inst, Euclid Ave, Cleveland, OH 44195 USA.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020; 6 (2): 105

Abstract

Background Recently, there has been an increasing interest in targeting inflammation to reduce major adverse cardiovascular events (MACE) in patients ......

Full Text Link